Twenty years ago, Maria Sainz faced an unusual fork in her career road. She chose wisely, building an esteemed career in Medtech that included senior leadership at Guidant and CEO posts at three Medtech start-ups. In this Medtech Talk Podcast, Sainz recounts the magic of Guidant, the merger with Boston Scientific, and her rewarding – and sometimes challenging – move into being a Medtech start-up CEO. She also talks about her current company’s post-approval trial strategy.
President & CEO
Maria Sainz was appointed President and CEO of Aegea Medical in May 2018. She has over 25 years experience in commercial and leadership positions in the medtech industry. Ms. Sainz has served as the President and CEO of Cardiokinetix, a medical device company pioneering a catheter-based treatment for heart failure and prior to that, she was the President and CEO of Concentric Medical, Inc., a developer of minimally invasive products for the treatment of acute ischemic stroke acquired in 2011 by Stryker Corporation. Maria begun her medtech career at Guidant corporation where she held positions of increasing responsibility. At Guidant she served as President, Cardiac Surgery division. Ms. Sainz also serves as a director of several public and private medical company boards. She received an M.A. in Languages from the University Complutense in Madrid, Spain and a Masters in International Management from the American Graduate School of International Management.
Meet Our Host
A follower and fan of medtech for nearly two decades, Tom Salemi is the former bureau chief, venture capital, at Elsevier Business Intelligence, where he oversaw coverage of venture investments in medtech.